Probiotics therapy in acute childhood diarrhoea
Probiotics therapy in acute childhood diarrhoea
复制标题
DOI：
10.1016/s0140-6736(10)61143-9
复制
发表时间：
2010-07
期刊：
影响因子：
--
通讯作者：
Z. Weizman
中科院分区：
文献类型：
--
作者：
Z. Weizman
Tessa Wardlaw和来自联合国儿童基金会和世界卫生组织的同事（3月13日，第870页）1讨论了一个重要的全球问题。他们的报告“腹泻：为什么儿童仍在死亡，可以做些什么”2包括一项计划，旨在加强对急性腹泻的管理，以提高全世界儿童的生存率。然而，Wardlaw及其同事忽略了益生菌疗法。各种益生菌在预防和治疗儿童急性腹泻方面进行了研究，具有很大的益处。3，4欧洲儿科胃肠病学和传染病学会联合委员会建议在这种疾病中使用选定的益生菌。因此，世界卫生组织和联合国儿童基金会等主要卫生组织应推荐使用益生菌疗法。反过来，这将鼓励进一步的研究，以描绘这种潜在的治疗工具的最佳使用。
Tessa Wardlaw and colleagues (March 13, p 870) 1 from UNICEF and WHO discuss a significant global issue. Their report “Diarrhoea: why children are still dying and what can be done” 2 includes a plan for upgrading manage ment of acute diarrhoea to improve child survival worldwide. However, Wardlaw and col leagues neglect to mention probiotics therapy. Various probiotics have been studied in the prevention and treatment of acute diarrhoea of childhood, with substantial benefit. 3, 4 A joint com mittee of the European Paediatric Societies for Gastroenterology and for Infectious Diseases recommended use of selected probiotics in this illness. 5 Accordingly, leading health author ities such as WHO and UNICEF should recommend use of probiotics therapy. This would, in turn, encourage further research to delineate the optimum use of this potential therapeutic tool.